Cohesive Technologies

About:

Cohesive Technologies Inc. designs, manufactures, and markets breakthrough liquid chromatography (LC) solutions for the drug discovery.

Top Investors: Mitsubishi UFJ Capital, Oxford Bioscience Partners, Psilos Group

Description:

Cohesive Technologies Inc. designs, manufactures, and markets breakthrough liquid chromatography (LC) solutions for the drug discovery, pharmaceutical, contract research, and clinical diagnostic industries. The company has developed patented technologies and a wide range of chromatographic products designed to significantly improve productivity by accelerating the separation, purification, and analysis of molecules in bioanalysis. With a strong depth of knowledge in column chemistry, applications, engineering, software development, and quality management, Cohesive Technologies leads the industry in the research, development, and production of LC technologies that accelerate the pace of customers' drug discovery and development efforts.

Total Funding Amount:

$23.1M

Headquarters Location:

Franklin, Massachusetts, United States

Founded Date:

1991-01-01

Contact Email:

info(AT)cohesivetech.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2003-07-02

IPO Status:

Private

Industries:

© 2025 bioDAO.ai